Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Nuvoco Vistas reported around 9% YoY growth in Q4FY26 revenue and outlined FY27 targets of 7-9% volume growth and EBITDA per tonne of Rs 900-plus.
Goldman Sachs kept its June 2027 Nifty target at 26,500 as ultra-light foreign positioning, rupee stability and softer commodities could help revive overseas inflows in FY27.
Social media discussions are breaking down how on-road price is built in India, with road tax, registration, insurance, FASTag, and EV exemptions driving major state-wise differences.
Dr Reddy’s shares slid after it flagged quality-linked API disruptions delaying generic semaglutide supplies until late October, raising the risk of missing its 12 million pen FY27 target.
Wood Mackenzie’s Q1 2026 outlook shows India’s GRM falling from FY23-24 peaks, with scenarios through 2028 shaped by EV demand shifts, crude sourcing risks, and product cracks.
HCLTech reports Q1FY27 results on July 13, with the Street tracking muted revenue trends, EBIT margins, deal wins, and whether FY27 guidance stays intact.
HCLTech reported FY26 revenue of ₹130,144 crore with EBIT margin at 17.2%, announced ₹60 dividend per share, and flagged softer discretionary spending and delayed decisions.
India’s June CPI narrative turned mixed, with polls flagging a rise above 4% while later commentary highlighted a 2.10% print and shifting RBI rate expectations.
HCL Technologies reports Q1FY27 today as brokerages expect modest sequential growth in rupee terms, resilient margins, and a close watch on FY27 guidance and dividends.
SBI and Axis Bank are leading a ₹15,000 crore term-loan syndicate for Aditya Birla Group’s all-cash Sprng Energy buyout, with MUFG in talks and a 5–10 year tenor under discussion.
A CNBC-TV18 report flagged a potential sale from Viatris-owned Mylan’s Biocon stake, as Viatris’ $815 million Biocon Biologics monetisation deal outlines cash, shares, and non-compete timelines.
Aditya Birla Group is in advanced talks with SBI and Axis Bank for a ₹15,000 crore term loan to fund an all-cash acquisition of Shell-owned Sprng Energy.
Biocon will acquire Viatris’ stake in Biocon Biologics for $815 million, alongside a parent-level integration plan and funding via a $500 million QIP and bridge loans.
CEA data for May 2026 shows renewable generation (excluding large hydro) up 29.92% YoY, as solar crossed 21.5 BU and capacity additions stayed strong in FY26.
Under the new CPI series, SBI Research said most states stayed below 3% inflation in January 2026, while Telangana rose to 4.92% against a national 2.75%.
Biocon reported successful Phase III data for its Yesafili biosimilar while Viatris-owned Mylan considers selling its 5.64% stake, creating near-term block-deal overhang.